Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 2 (2006), Issue 11 (November)

1. Maternal hemoglobin concentration during pregnancy and risk of infant leukaemia: a children's oncology group study.
   Br J Cancer, 95(9): 1274-6. [Abstract] [Full-text]
2. Exposure to medical test irradiation and acute leukemia among children with Down syndrome: a report from the Children's Oncology Group.
   Pediatrics, 118(5): e1499-508. [Abstract] [Full-text]
3. Antiepileptic treatment in paediatric oncology--an interdisciplinary challenge.
   Klin Padiatr, 218(6): 340-9. [Abstract] [Full-text]
4. Multidisciplinary care in oncology: medicolegal implications of group decisions.
   Lancet Oncol, 7(11): 951-4. [Abstract] [Full-text]
5. A multi-institution, minimally invasive urological oncology fellowship: a critical assessment of the clinical training and academic benefits.
   J Urol, 176(6): 2619-23; discussion 2623. [Abstract] [Full-text]
6. Inequalities in oncology care: Economic consequences of high cost drugs.
   Eur J Cancer, 42(17): 2887-92. [Abstract] [Full-text]
7. Gynecologic oncology patients' satisfaction and symptom severity during palliative chemotherapy.
   Health Qual Life Outcomes, 4: 84. [Abstract] [Full-text]
8. Advanced practice nursing in radiation oncology.
   Semin Oncol Nurs, 22(4): 203-11. [Abstract] [Full-text]
9. Role of the radiation oncology nurse.
   Semin Oncol Nurs, 22(4): 198-202. [Abstract] [Full-text]
10. A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06.
    Radiother Oncol, 81(2): 136-42. [Abstract] [Full-text]
11. Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology.
    J Clin Epidemiol, 59(12): 1257-65. [Abstract] [Full-text]
12. Neoplastic stem cells: a novel therapeutic target in clinical oncology.
    Cancer, 107(10): 2512-20. [Abstract] [Full-text]
13. Cytomics - importance of multimodal analysis of cell function and proliferation in oncology.
    Cell Prolif, 39(6): 495-505. [Abstract] [Full-text]
14. A pilot audit of weight loss in upper gastrointestinal oncology outpatients.
    J Hum Nutr Diet, 19(6): 447-50. [Abstract] [Full-text]
15. Risk factors for Clostridium difficile-associated diarrhea on an adult hematology-oncology ward.
    Eur J Clin Microbiol Infect Dis, 25(12): 751-5. [Abstract] [Full-text]
16. Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902.
    J Clin Oncol, 24(33): 5247-52. [Abstract] [Full-text]
17. Imaging response assessment in oncology.
    Cancer Imaging, 6: S126-30. [Abstract] [Full-text]
18. A systematic review on drug interactions in oncology.
    Cancer Invest, 24(7): 704-12. [Abstract] [Full-text]
19. A Pilot Phase II Trial of Valspodar Modulation of Multidrug Resistance to Paclitaxel in the Treatment of Metastatic Carcinoma of the Breast (E1195): A Trial of the Eastern Cooperative Oncology Group.
    Cancer Invest, 24(7): 677-81. [Abstract] [Full-text]
20. Impact of telemedicine on pediatric neuro-oncology in a developing country: the Jordanian-Canadian experience.
    Pediatr Blood Cancer, 48(1): 39-43. [Abstract] [Full-text]
21. Attitudes and practices of pediatric oncology providers regarding fertility issues.
    Pediatr Blood Cancer, 48(1): 80-5. [Abstract] [Full-text]
22. Risk adjusted surgical audit in gynaecological oncology: P-POSSUM does not predict outcome.
    Eur J Surg Oncol, 32(10): 1135-8. [Abstract] [Full-text]
23. Intensified CHOP of 12-weeks duration (I-CHOP) plus G-CSF compared with standard CHOP of 24-weeks duration (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin's Lymphoma. A phase III trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON).
    Blood. [Abstract] [Full-text]
24. Cancer stem cells and oncology therapeutics.
    Curr Opin Oncol, 19(1): 61-4. [Abstract] [Full-text]
25. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.
    J Clin Oncol, 24(34): 5448-53. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.